Category: Biotech, Food, Drug

DOJ Files FCA Against Major Pharmacy Retailer on the Basis of Allegations of Violations under Controlled Substances Act

DEA Issues Proposed Rule for Prescribing of Controlled Substances via Telemedicine

Insurance Options for Cannabis Businesses Slowly Improving

Ramifications of FDA’s Proposed Action Levels for Heavy Metals in Baby Food

DEA Proposes Rule for Post-PHE Telemedicine

FDA launches Dietary Supplement Ingredient Database

Comment on CMS Guidance regarding the Medicare Prescription Drug Inflation Rebate Programme Due March 11, 2023

The Wait is over. . . Or is it? Proposed Rules for Telemedicine Prescribing by the DEA: Initial Impressions and Key Takeaways

Update on FDA’s Prevention Strategies to Improve Food Safety

The Health AI Frontier: Innovation Opportunities in the Health Care Sector

Unpacking Averages: Exploring New Data on FDA Responses to FOIA Requests

FDA asked to allow “healthy” claims on coffee